Ignite Creation Date:
2025-12-24 @ 10:47 PM
Ignite Modification Date:
2026-04-10 @ 6:51 AM
Study NCT ID:
NCT06543069
Status:
RECRUITING
Last Update Posted:
2024-08-07
First Post:
2024-08-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM
Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NCC4469
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None